Aspirin: "Protects" from the serious side effects of the coronavirus | Covid-19 Tests Thessaloniki | Aegean Medical Services
Aegean Medical

Covid-19 test Thessaloniki. Medical-specialized network which, among other services, performs molecular covid-19 tests. The best medical services across every corner of Greece. Offering 24/7 medical supportin order to experience hassle free vacations

Aegean Medical Network
THESSALONIKI
+ 30 698 111 0786

KASTORIA
+ 30 698 111 0786

STAVROS
+ 30 698 111 0786

ASPROVALTA
+ 30 698 111 0786

VRASNA
+ 30 698 111 0786

HANIOTI
+ 30 698 111 0786

POLYCHRONO
+ 30 698 111 0786

PEFKOCHORI
+ 30 698 111 0786

N. MARMARAS
+ 30 698 111 0786

NIKITI
+ 30 698 111 0786

SARTI
+ 30 698 111 0786

AIDIPSOS
+ 30 698 111 0786

PEFKI
+ 30 698 111 0786

Follow Us On Instagram

Monday - Sunday | 7-21:30h Support

7-21:30h - Call support at your disposal

+30 698 517 9999   +30 698 111 0786

info@aegeanmedical.gr

Multiple offices in Greece

Locations all over the Greece

Follow Us

Aspirin: “Protects” from the serious side effects of the coronavirus

Aspirin: “Protects” from the serious side effects of the coronavirus

According to a new study of the University of Maryland School of Medicine, Aspirin reduces the risk of death in clinical patients with coronavirus.According to the above study, clinical patients with coronavirus, who received low-dose aspirin on a daily basis for cardiovascular disease, had a lower risk of complications and death than those who did not, and were less likely to be connected to mechanical ventilation or in Intensive Care Unit (ICU).

 

The restrained optimism of researchers

The study, published in the journal Anesthesia and Analgesia, gives us “moderate optimism”, according to  researchers, about a cheap, affordable drug known for its safety profile that could help prevent potentially serious and even fatal complications.

“This is a critical finding that needs to be confirmed through a randomized clinical trial,” said study leader Jonathan Chow, an assistant professor of anesthesiology at the University of Maryland School of Medicine. “If our finding is confirmed, it would make aspirin the first widely available over-the-counter drug to reduce mortality in patients with Covid-19.”

stethoscope-4926153_1920

47% lower risk of death The sample of patients whose medical records were examined with Covid-19 and who were used for the study were on average 55 years old and were hospitalized in the last months. To conduct the study, Dr. Chow and his colleagues looked at the medical records of Covid-19 patients, an average of 55 years old, who had been hospitalized in recent months due to complications of the infection. According to the results of this study, in a quarter of patients taking a low daily dose of aspirin before or immediately after admission to manage their cardiovascular disease, the following were found: (a) A 47% reduction in risk of death (b)) 43% reduction in ICU admission and finally (c) 44% reduction in the need for a mechanical ventilator.

Also patients receiving aspirin did not show a significant increase in side effects such as heavy bleeding during their hospitalization.

syringe-1884784_1920

Exploring the link between aspirin and Covid-19

Infection caused by the new coronavirus increases the risk of dangerous blood clots, which can form in the heart, lungs, blood vessels and other organs. Complications from blood clots can, in rare cases, cause heart attacks, strokes, multiple organ failure, and death.

In conclusion, study author Michael A. Mazzeffi, Associate Professor of Anesthesiology at the University of Maryland School of Medicine, states: “We believe that the effect of aspirin on blood thinning provides benefits for patients with Covid-19, preventing the formation of blood clots”.

Sometimes infected people can be asymptomatic, so make sure book a Covid-19 test appointment at home with Aegean Medical Service

Contact details for an appointment: tel. +30 698 517 9999, email: info@aegeanmedical.gr

Aegean Medical